Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
Lancet
.
2024 Jan 13;403(10422):e2-e4.
doi: 10.1016/S0140-6736(23)00282-9.
Epub 2023 Feb 9.
Authors
Christine Årdal
1
,
Enrico Baraldi
2
,
Reinhard Busse
3
,
Rosa Castro
4
,
Francesco Ciabuschi
5
,
José Miguel Cisneros
6
,
Inge C Gyssens
7
,
Stephan Harbarth
8
,
Tomislav Kostyanev
9
,
Yohann Lacotte
10
,
Nicola Magrini
11
,
Anthony McDonnell
12
,
Annelie A Monnier
13
,
Suerie Moon
14
,
Elias Mossialos
15
,
Germán Peñalva
16
,
Marie-Cécile Ploy
10
,
Momir Radulović
17
,
Adrián Alonso Ruiz
14
,
John-Arne Røttingen
18
,
Michael Sharland
19
,
Evelina Tacconelli
20
,
Ursula Theuretzbacher
21
,
Sabine Vogler
22
,
Ute Wolff Sönksen
23
,
Kerstin Åkerfeldt
24
,
Otto Cars
24
,
Jim O'Neill
25
Affiliations
1
Antimicrobial Resistance Centre, Norwegian Institute of Public Health, Oslo 0213, Norway. Electronic address: chaa@fhi.no.
2
Department of Engineering Sciences, Industrial Engineering and Management, Uppsala University, Uppsala, Sweden.
3
Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
4
European Public Health Alliance, Brussels, Belgium.
5
Department of Business Studies, Uppsala University, Uppsala, Sweden.
6
Department of Infectious Diseases, University Hospital Virgen del Rocio, IBiS, CIBERINFEC, Seville, Spain.
7
Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
8
Hôpitaux Universitaires de Genève, Geneva, Switzerland.
9
Laboratoire National de Santé, Dudelange, Luxembourg.
10
University of Limoges, INSERM, CHU Limoges, RESINFIT, Limoges, France.
11
AIFA-Italian Medicines Agency, Rome, Italy.
12
Center for Global Development, London, UK.
13
Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
14
Graduate Institute of International and Development Studies, Geneva, Switzerland.
15
London School of Economics and Political Science, London, UK.
16
Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/University Hospital Virgen del Rocio, Seville, Spain.
17
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Ljubljana, Slovenia.
18
Norwegian Ministry of Foreign Affairs, Oslo, Norway.
19
Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
20
University of Verona, Verona, Italy.
21
Center for Anti-Infective Agents, Vienna, Austria.
22
Austrian National Public Health Institute, Vienna, Austria; Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
23
Statens Serum Institut, Copenhagen, Denmark.
24
ReAct Europe, Uppsala University, Uppsala, Sweden.
25
The Review on Antimicrobial Resistance, London, UK.
PMID:
36774936
DOI:
10.1016/S0140-6736(23)00282-9
No abstract available
MeSH terms
Anti-Bacterial Agents*
Humans
Motivation*
Substances
Anti-Bacterial Agents